Trusting the Process and Celebrating Triumphs Growing up in Cleveland, Ohio, Steven M. Horwitz, MD, a Medical Oncologist at Memorial Sloan Kettering Cancer Center, member of LRF’s Scientific Advisory Board, and co-chair of LRF’s Lymphoma Scientific Research Mentoring Program (LSRMP),…
When did you become interested in the study of medicine? In lymphoma? As a result of my father’s job as a diplomat, I lived in Brazil during high school and had the opportunity to volunteer in a clinic in the…
Right Place at the Right Time Sometimes, life has a strange way of preparing us for what’s ahead, even though we might not realize it at the time. For Tawny Roeder, a 37-year-old part-time nurse, and full-time wife and mother…
Statement of Lymphoma Research on Access to Quality Cancer Care In Response to Dobbs V. Jackson Women’s Health Organization The Lymphoma Research Foundation (LRF) is dedicated to ensuring that lymphoma patients have access to quality care that is evidence-based, medically…
Lymphoma Research Foundation Names Sarah Quinlan Chief Program Officer The Lymphoma Research Foundation (LRF) – the nation’s largest non-profit organization dedicated exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive series of education programs, outreach…
The U.S. Food and Drug Administration Approves Lisocabtagene Maraleucel (Breyanzi) for Large B-Cell Lymphoma On June 24, 2022, the U.S. Food and Drug Administration (FDA) announced it has approved the use of lisocabtagene maraleucel (liso-cel, Breyanzi), a chimeric antigen receptor…